Cardiology Now
By Cardiology Now
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Cardiology Now
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 14
Reviews: 0
Episodes: 162
Description
News and Views
| Episode | Date |
|---|---|
|
Peripheral Arterial Disease: MACE and MALE Including Leg Amputation
|
May 14, 2018 |
|
Organizing and Actualizing a Polypharmacy
|
May 14, 2018 |
|
Clinician Education about Peripheral Arterial Disease
|
Apr 27, 2018 |
|
Vascular Access Complications
|
Apr 27, 2018 |
|
SCAI Global Focus
|
Apr 27, 2018 |
|
The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock: Insights From the British Columbia Cardiac Registry
|
Apr 27, 2018 |
|
Emerging Leader Mentorship (ELM) Program
|
Apr 27, 2018 |
|
Patient Education in the Peripheral Arterial Disease Space
|
Apr 27, 2018 |
|
Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes After Percutaneous Coronary Intervention: A Subgroup Analysis of the Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial
|
Apr 27, 2018 |
|
Short-Term DAPT Studies
|
Apr 27, 2018 |
|
SCAI Consensus Statement for Length of Stay after PCI
|
Apr 27, 2018 |
|
The Presidential Address and Goals for SCAI 2019
|
Apr 27, 2018 |
|
Practical Considerations for Intermediate Risk Patients in TAVR
|
Apr 26, 2018 |
|
Innovations from Female Physicians in Pediatric Cardiology
|
Apr 26, 2018 |
|
SCAI Transition for Value Initiative and Transradial Access
|
Apr 26, 2018 |
|
Insights from the Hildner Keynote
|
Apr 26, 2018 |
|
SCAI Peripheral Vascular Disease Device Selection
|
Apr 26, 2018 |
|
SCAI PAD Toolkit for Interventional Cardiologists and Primary Care Physicians
|
Apr 26, 2018 |
|
TAVR in Bicuspid Valve Patients
|
Apr 26, 2018 |
|
SCAI Quality Improvement Apps
|
Apr 26, 2018 |
|
Transradial CHIP and SAFE STEMI for Seniors
|
Apr 25, 2018 |
|
New Tools for the CPCI Toolbox
|
Apr 25, 2018 |
|
SCAI 2018 Expectations
|
Apr 25, 2018 |
|
Management of Cardiogenic Shock
|
Apr 25, 2018 |
|
Founders Lecture: A 40-year Journey in Evidence Based Medicine
|
Apr 25, 2018 |
|
ORBITA Trial & Panel Discussion
|
Apr 25, 2018 |
|
Prevention of Cardiovascular Events in PAD and the Role of Anticoagulation
|
Apr 17, 2018 |
|
Preventing Heart Attack, Stroke, and Major Adverse Limb Events in Patients with Stable Atherosclerotic Vascular Disease
|
Apr 10, 2018 |
|
2018 Imaging for Plaque Characterization
|
Apr 03, 2018 |
|
The ICON-RELOADED Study: A New Future for NT-proBNP
|
Mar 21, 2018 |
|
ACC 2018 Wrap Up in Turkish
|
Mar 15, 2018 |
|
POISE: 1-Year Outcomes of Perioperative Beta-blockade in Noncardiac Surgery
|
Mar 12, 2018 |
|
TRIUMPH: Low-dose Triple-Combination BP Lowering Pill for Initial Treatment of Hypertension
|
Mar 12, 2018 |
|
Cavitation Phenomenon Damages the Endothelium and Starts the Atherosclerotic Process
|
Mar 12, 2018 |
|
Blood Pressure Reduction in Black Barbershops
|
Mar 12, 2018 |
|
PHARMACLO: A Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Acute Coronary Syndrome
|
Mar 12, 2018 |
|
MOMENTUM III: HeartMate III demonstrated 2-year Survival Benefit Compared to HeartMate II
|
Mar 12, 2018 |
|
CANTOS subanalysis: Effect of Canakinumab on New Onset Diabetes in Pre-Diabetic Patients
|
Mar 12, 2018 |
|
ACC 2018 – Wrap Up in German
|
Mar 12, 2018 |
|
TREAT: Ticagrelor vs. Clopidogrel After Thrombolytic Therapy in STEMI Patients
|
Mar 12, 2018 |
|
ACC 2018 – Wrap Up from a Pacific Rim Perspective
|
Mar 12, 2018 |
|
ACC 2018 – Wrap Up from a Canadian Perspective
|
Mar 12, 2018 |
|
ACC 2018 Wrap-up in Arabic
|
Mar 12, 2018 |
|
CANTOS Trial: Canakinumab Reduces MACE and Mortality Among CKD Patients
|
Mar 11, 2018 |
|
ACC 2018 Daily Wrap-Up – March 11, 2018
|
Mar 11, 2018 |
|
ACC 2018 Daily Wrap-Up – March 10, 2018
|
Mar 11, 2018 |
|
ACC 2018 Hebrew Wrap Up
|
Mar 11, 2018 |
|
ACC 2018 Wrap-Up: Prof. Freek Verheugt’s Perspective
|
Mar 11, 2018 |
|
ACC 2018 Japanese Wrap-Up
|
Mar 11, 2018 |
|
ACC 2018 Italian Wrap Up
|
Mar 11, 2018 |
|
MANAGE Trial: Dabigatran in Patients With MI After Non-Cardiac Surgery
|
Mar 11, 2018 |
|
ODYSSEY Outcomes: Alirocumab Reduces CV Outcomes and All-Cause Mortality in ACS Patients
|
Mar 11, 2018 |
|
VEST trial: Prevention of Early Sudden Death Post-MI
|
Mar 11, 2018 |
|
SWAP 4: Switching from Ticagrelor to Clopidogrel in Patients with Coronary Artery Disease
|
Mar 11, 2018 |
|
Incorporating Non-Invasive Fractional Flow Reserve into Clinical Practice
|
Mar 04, 2018 |
|
Anticipating ODYSSEY Outcomes
|
Feb 22, 2018 |
|
Critical Limb Ischemia: Overview and Unmet Needs
|
Feb 08, 2018 |
|
AHA 2017 Wrap-Up in Romanian
|
Nov 14, 2017 |
|
AHA 2017 Wrap-Up in Hebrew
|
Nov 14, 2017 |
|
AHA 2017 Wrap-Up in Japanese
|
Nov 14, 2017 |
|
AHA 2017 Wrap-Up in French
|
Nov 14, 2017 |
|
AHA 2017 Wrap-Up from a Pacific Rim Perspective
|
Nov 14, 2017 |
|
AHA 2017 Wrap-Up from the Perspective of the Netherlands
|
Nov 14, 2017 |
|
AHA 2017 Wrap-Up in Arabic
|
Nov 14, 2017 |
|
AHA 2017 Wrap-Up in Portuguese
|
Nov 14, 2017 |
|
GM- CSF and Supervised Exercise in PAD
|
Nov 14, 2017 |
|
Implementation of Evidence-Based Treatments in NSTEMI Outcomes
|
Nov 14, 2017 |
|
Transcatheter Inter-atrial Shunt Device for Treatment of HF
|
Nov 14, 2017 |
|
Bariatric Surgery in Obese Patients with HTN
|
Nov 14, 2017 |
|
Effects of Exenatide in Type 2 DM and CVD
|
Nov 14, 2017 |
|
Outcomes with Primary Angioplasty and Prasugrel vs Ticagrelor
|
Nov 14, 2017 |
|
TRICS III – Transfusion Triggers in Cardiac Surgery
|
Nov 14, 2017 |
|
Temporary Neurotoxin Treatment to Prevent Postop AFib
|
Nov 14, 2017 |
|
ALLSTAR: ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration
|
Nov 12, 2017 |
|
STEMI ACCELERATOR-2 – Regional STEMI Systems of Care
|
Nov 12, 2017 |
|
Opportunities to Improve Outcomes for CV Emergencies in the US
|
Nov 12, 2017 |
|
BP Measurement in the SBP Intervention Trial
|
Nov 12, 2017 |
|
Continued versus Interrupted NOAC at the time of Device Surgery
|
Nov 12, 2017 |
|
Critical Analysis from the CANTOS Trial
|
Nov 12, 2017 |
|
Does High-Intensity Pitavastatin Therapy Improve Clinical Outcomes?
|
Nov 12, 2017 |
|
FOURIER – Evolocumab and Outcomes in PAD
|
Nov 12, 2017 |
|
ESC 2017 Wrap-Up from a Pacific Rim Perspective
|
Aug 29, 2017 |
|
ESC 2017 Wrap-Up in Romanian
|
Aug 29, 2017 |
|
Does intensive statin lowering therapy in diabetic retinopathy reduce CV events?
|
Aug 29, 2017 |
|
ESC 2017 Wrap-Up in French
|
Aug 29, 2017 |
|
ESC 2017 Wrap-Up from a Scandinavian Perspective
|
Aug 29, 2017 |
|
CV Outcomes for People using Anticoagulation Strategies (COMPASS) trial
|
Aug 29, 2017 |
|
SPYRAL HTN OFF-MED Study
|
Aug 29, 2017 |
|
TCT 2017 Wrap-Up in German
|
Aug 28, 2017 |
|
ESC 2017 Wrap-Up in Italian
|
Aug 28, 2017 |
|
ESC 2017 Wrap-Up in Japanese
|
Aug 28, 2017 |
|
ESC 2017 Wrap-Up from the Perspective of the Netherlands
|
Aug 28, 2017 |
|
ESC 2017 Wrap-Up in Hebrew
|
Aug 28, 2017 |
|
ESC 2017 Wrap-Up in Portuguese
|
Aug 28, 2017 |
|
Remote Heart Rhythm Sampling to screen for AFib
|
Aug 28, 2017 |
|
Tracheal intubation versus BMV during CPR
|
Aug 28, 2017 |
|
Sildenafil in Corrected Valvular Heart Disease and Residual PH
|
Aug 28, 2017 |
|
Oral Anticoagulants in Atrial Fibrillation
|
Aug 28, 2017 |
|
Protection of the brain during open heart surgery by surgical LAAO
|
Aug 28, 2017 |
|
Viborg Vascular randomised screening trial
|
Aug 28, 2017 |
|
Canakinumab Anti-Inflammatory Thrombosis Outcomes Study
|
Aug 25, 2017 |
|
Apixaban vs conventional therapy in patients with AFib undergoing cardioversion
|
Aug 25, 2017 |
|
Origins and Future of the PE Response Team
|
May 12, 2017 |
|
Message from the Outgoing SCAI President
|
May 12, 2017 |
|
Take-Aways from the Cardio-Oncology Workshop
|
May 12, 2017 |
|
PLATINUM DIVERSITY Outcomes and SCAI Women in Innovations
|
May 12, 2017 |
|
Interventional Coronary Physiology: A 30-Year Overnight Success Story
|
May 12, 2017 |
|
State of the Art in Transseptal Therapies
|
May 12, 2017 |
|
Top Sessions for Cardiovascular Professionals at SCAI 2017
|
May 12, 2017 |
|
Opportunities and Challenges for the Cardiovascular Interventionalists
|
May 12, 2017 |
|
SCAI’s New Executive Director
|
May 12, 2017 |
|
Intersection of Coronary Artery Disease and TAVR
|
May 12, 2017 |
|
Pediatric Interventional Cardiology: Alice in Wonderland or Fred Astaire and Ginger Rogers?
|
May 11, 2017 |
|
Pediatric VSD: What Is It?
|
May 11, 2017 |
|
SCAI Global Partnerships
|
May 11, 2017 |
|
The Presidential Address and Goals for SCAI 2018
|
May 11, 2017 |
|
Reintroduction of live cases
|
May 11, 2017 |
|
State of the Art in PFO
|
May 11, 2017 |
|
Effect of Bivalirudin Versus UFH in Patients with AFib in TAVR
|
May 11, 2017 |
|
Importance of Patient Education
|
May 11, 2017 |
|
T4V Launch and Transradial for CHIP/CTO
|
May 11, 2017 |
|
The C3 Summit
|
May 11, 2017 |
|
State of the Art in BVS
|
May 11, 2017 |
|
Intersection of CAD and TAVR
|
May 11, 2017 |
|
Fall Fellows: What to Expect and Why Attend?
|
May 11, 2017 |
|
Outcomes of Radial vs. Femoral-Access Robotic PCI
|
May 11, 2017 |
|
CD34+ Stem Cell Therapy Improves Mortality in Refractory Angina
|
May 10, 2017 |
|
Cath Lab Boot Camp
|
May 10, 2017 |
|
State of the Art in Mitral Valve Replacement
|
May 10, 2017 |
|
Highlights from the CHD Track
|
May 10, 2017 |
|
State of the Art in CPVI
|
May 10, 2017 |
|
Social Media for the Cardiologist
|
May 10, 2017 |
|
Current Trends in Cardiogenic Shock
|
May 10, 2017 |
|
Women in Cardiology
|
May 10, 2017 |
|
SCAI 2017 Highlights
|
May 10, 2017 |
|
History of SCAI – 40th Anniversary
|
May 10, 2017 |
|
ACC 2017 Wrap-Up in German
|
Mar 19, 2017 |
|
Digoxin in AFib With and Without Heart Failure
|
Mar 19, 2017 |
|
ACC 2017 Wrap-Up from the Perspective of the Netherlands
|
Mar 19, 2017 |
|
ACC 2017 Wrap-Up from the Perspective of the Pacific Rim
|
Mar 19, 2017 |
|
ACC 2017 Wrap-Up in Hebrew
|
Mar 19, 2017 |
|
Effect of CER-001 on Coronary Atherosclerosis
|
Mar 19, 2017 |
|
CV Outcomes Research With PCSK9 Inhibition
|
Mar 19, 2017 |
|
ACC 2017 Wrap-Up in Portuguese
|
Mar 18, 2017 |
|
ACC 2017 Wrap-Up in Italian
|
Mar 18, 2017 |
|
Everolimus-Eluting Bioresorbable Vascular Scaffolds in CAD
|
Mar 18, 2017 |
|
Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope
|
Mar 18, 2017 |
|
Relationship Between High Troponin T and Mortality After Noncardiac Surgery
|
Mar 18, 2017 |
|
Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Aortic Valves
|
Mar 18, 2017 |
|
FFR Guided Acute Complete Revascularization VS Culprit Lesion Only Treatment in STEMI
|
Mar 18, 2017 |
|
Safety and Cardiovascular Event Efficacy of Bococizumab
|
Mar 18, 2017 |
|
TAVR With a Self-Expanding Bioprosthesis Compared With Surgical AVR
|
Mar 18, 2017 |
|
Rivaroxaban or Aspirin for Extended Treatment of VTE
|
Mar 18, 2017 |
|
e-Counseling Adds Therapeutic Benefit for HTN
|
Mar 18, 2017 |
|
Silent Cerebral Microbleeds During TAVR
|
Mar 17, 2017 |
|
Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention
|
Mar 17, 2017 |
|
EBBINGHAUS: Cognitive Study of Patients Enrolled in the FOURIER Trial
|
Mar 17, 2017 |
|
Bleeding With Low-Dose Rivaroxaban Versus Aspirin After ACS
|
Mar 17, 2017 |
|
LAAO Among AFib Patients Undergoing Cardiac Surgery
|
Mar 17, 2017 |
|
Outcomes of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization
|
Mar 17, 2017 |
|
Dabigatran vs Warfarin in Patients Undergoing Catheter Ablation of AFib
|
Mar 17, 2017 |
|
Levosimendan in Patients With LV Systolic Dysfunction Undergoing Cardiac Surgery
|
Mar 17, 2017 |